Template:Asthma guidelines/NHLBI EPR-3

From Wiki Journal Club
Jump to navigation Jump to search

National Health Lung and Blood Institute EPR-3 (2007, adapted)[1]

  • Mild to moderate persistent asthma:
    • Therapy should be monitored at 2-6 week intervals to ensure asthma control.
    • It is recommended to perform periodic (1-6 month) assessments of asthma control and the need for therapy adjustments.
    • Measurements of asthma control are the following: signs and symptoms of asthma, pulmonary function, quality of life, and history of exacerbations.
    • A written asthma action plan is recommended for all patients and can be symptom or peak-flow based.